CLINICAL_TRIALS
trial_result
· 2013-07-26
Clinical Trial Update: Targeting INflammation Using SALsalate in Type 2 Diabetes (TINSAL-T2D) [Phase 2, Phase 3]
Summary
Clinical trials evaluating SALsalate targeting inflammation in type 2 diabetes have completed Phase 2 and Phase 3 with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Joslin Diabetes Center | Conditions: Type 2 Diabetes | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2013-07-26